Paul Saladino· MD
I am extremely dejected by clinical trials because they are done predominantly by the pharmaceutical industry these clinical trials are done in 25 countries at 400 centers the pharmaceutical industry funds these trials they gather all the data they hire experts to analyze this data so the degree of bias in excluding somebody like let's say I was on a pcsk9 inhibitor and I had an event but I am also the one who is running the trial and I would like to somehow find reasons to exclude that patient from being included in the endpoint analysis